The metabolic syndrome: common origins of a multifactorial disorder
The metabolic syndrome: common origins of a multifactorial disorder
The metabolic syndrome (MetS) represents a combination of cardiometabolic risk determinants including obesity (central adiposity), insulin resistance, glucose intolerance, dyslipidaemia, non-alcoholic fatty liver disease and hypertension. MetS is rapidly increasing in prevalence worldwide as a consequence of the continued obesity “epidemic”, and as a result will have a considerable impact on the global incidence of cardiovascular disease and type 2 diabetes. Currently, there is debate concerning whether the risk of cardiovascular disease is greater in patients diagnosed with MetS than that of the sum of the individual risk factors. At present, no unifying origin that can explain the pathogenesis of MetS has been identified and therefore no unique pharmacological treatment is available. This review summarises and critically evaluates the current clinical and scientific evidence supporting the existence of MetS as a multifactorial endocrine disease, for which maternal nutrition may be a common pathogenic mechanism. In addition, we suggest that ectopic fat accumulation (such as visceral and hepatic fat accumulation) and the proinflammatory state are central to the development of the MetS.
614-621
Bruce, K.D.
1ded890b-addf-45bd-ba59-dbaedaeee931
Byrne, C.D.
1370b997-cead-4229-83a7-53301ed2a43c
November 2009
Bruce, K.D.
1ded890b-addf-45bd-ba59-dbaedaeee931
Byrne, C.D.
1370b997-cead-4229-83a7-53301ed2a43c
Bruce, K.D. and Byrne, C.D.
(2009)
The metabolic syndrome: common origins of a multifactorial disorder.
Postgraduate Medical Journal, 85 (1009), .
(doi:10.1136/pgmj.2008.078014).
Abstract
The metabolic syndrome (MetS) represents a combination of cardiometabolic risk determinants including obesity (central adiposity), insulin resistance, glucose intolerance, dyslipidaemia, non-alcoholic fatty liver disease and hypertension. MetS is rapidly increasing in prevalence worldwide as a consequence of the continued obesity “epidemic”, and as a result will have a considerable impact on the global incidence of cardiovascular disease and type 2 diabetes. Currently, there is debate concerning whether the risk of cardiovascular disease is greater in patients diagnosed with MetS than that of the sum of the individual risk factors. At present, no unifying origin that can explain the pathogenesis of MetS has been identified and therefore no unique pharmacological treatment is available. This review summarises and critically evaluates the current clinical and scientific evidence supporting the existence of MetS as a multifactorial endocrine disease, for which maternal nutrition may be a common pathogenic mechanism. In addition, we suggest that ectopic fat accumulation (such as visceral and hepatic fat accumulation) and the proinflammatory state are central to the development of the MetS.
Text
Bruce_and_Byrne_PMJ_2009.pdf
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Published date: November 2009
Identifiers
Local EPrints ID: 72771
URI: http://eprints.soton.ac.uk/id/eprint/72771
ISSN: 0032-5473
PURE UUID: 44c500ea-1e25-4d71-b151-4edc4b6ba183
Catalogue record
Date deposited: 22 Feb 2010
Last modified: 14 Mar 2024 02:43
Export record
Altmetrics
Contributors
Author:
K.D. Bruce
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
